PowerPoint Presentation

Research in NMSC www.clinicaltrials.gov

NMSC - 130 clinical trials, 23 recruiting

Targeted therapies / novel agents in various advanced / refractory neoplasms incl. NMSC 8 Prevention 5 Imaging 2 Retrospective 2 : Electronic BT vs Mohs – 1, Cetuximab 1

Predicting outcomes 1 Alfa radiation emitters 1 Decision support tools for GPs 1 Histopathological diagnosis 1

Clinical intervention in NMSC: Pembrolizumab 1 – phase II, open label Cetuximab 1 – pilot, open label

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> Planned RCT phase III – pembrolizumab vs. placebo, double blind